Painless eye drops aim to save sight in kids with brain tumors
Disease control
Ongoing
This study tests whether a new painless nerve growth factor eye drop (CHF6467) can protect vision in children and young adults with optic pathway glioma, a type of brain tumor that often causes vision loss. The trial involves 36 participants aged 3 to 40 who will receive either t…
Phase: PHASE2 • Sponsor: Benedetto Falsini • Aim: Disease control
Last updated Jun 17, 2026 07:25 UTC